NSC 145366

CAS No. 1052515-37-3

NSC 145366( NSC145366 )

Catalog No. M10250 CAS No. 1052515-37-3

NSC 145366 is a novel, allosteric Hsp90 CTD (C-terminal domain) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NSC 145366
  • Note
    Research use only, not for human use.
  • Brief Description
    NSC 145366 is a novel, allosteric Hsp90 CTD (C-terminal domain) inhibitor.
  • Description
    NSC 145366 is a novel, allosteric Hsp90 CTD (C-terminal domain) inhibitor, exhibits anti-proliferative activity in tumor cell lines with GI50 of 0.2-1.9 uM; increases Hsp90 oligomerization resulting in allosteric inhibition of NTD ATPase activity (IC50=119 uM), but does not compete with NTD or CTD-ATP binding; causes selective client protein downregulation including AR and BRCA1 but without a heat shock response in LNCaP prostate tumor cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC145366
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    HSP
  • Recptor
    HSP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1052515-37-3
  • Formula Weight
    635.371
  • Molecular Formula
    C37H63ClN2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C1=CC=C(OCC(O)CNC(C)(C)CC(C)(C)C)C=C1)(C2=CC=C(OCC(O)CNC(C)(C)CC(C)(C)C)C=C2)C.[H]Cl.[H]Cl
  • Chemical Name
    1-[4-[2-[4-[2-hydroxy-3-(2,4,4-trimethylpentan-2-ylamino)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2,4,4-trimethylpentan-2-ylamino)propan-2-ol hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Thomas FM, et al. SLAS Discov. 2017 Jul;22(6):706-719. 2. Goode KM, et al. Biochim Biophys Acta. 2017 Aug;1861(8):1992-2006.
molnova catalog
related products
  • JG-98

    JG-98 is an allosteric Hsp70 inhibitor, displays >3-fold more active, greater stability than MKT-077 against the breast cancer cell lines MDA-MB-231 and MCF-7 (EC50 of 0.4 uM and 0.7 uM, respectively).

  • NPX800

    NPX800 is an inhibitor of heat shock factor 1 (HSF1) and can be used in studies about the treatment of cancer.

  • KU675

    A novel, second-generation C-terminal Hsp90 inhibitor with Kd of 191 and 726 uM for Hsp90α and Hsp90β, respectively.